Enhanced GABA Transmission Drives Bradykinesia Following Loss of Dopamine D2 Receptor Signaling
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Summary Bradykinesia is a prominent phenotype of Parkinson’s disease, depression, and other neurological conditions. Disruption of dopamine transmission plays an important role but progress in understanding the exact mechanisms driving slowness of movement has been impeded due to the heterogeneity of DA receptor distribution on multiple cell types within the striatum. Here we show that selective deletion of DA D2 receptors (D2Rs) from indirect-pathway medium spiny neurons (iMSNs) is sufficient to impair locomotor activity, phenocopying DA depletion models of Parkinson’s disease, despite this mouse model having intact DA transmission. There was a robust enhancement of GABAergic transmission and a reduction of in vivo firing in striatal and pallidal neurons. Mimicking D2R signaling in iMSNs with Gi-DREADDs restored the level of tonic GABAergic transmission and rescued the motor deficit. These findings indicate that DA, through D2R activation in iMSNs, regulates motor output by constraining the strength of GABAergic transmission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry
Kravitz, A. V., Freeze, B. S., Parker, P. R. L., Kay, K., Thwin, M. T., Deisseroth, K., & Kreitzer, A. C. (2010) · Nature · doi:10.1038/nature09159 · Cited by 1,885 · cited 3×
“Indeed, manipulations of dMSN and iMSN activity have provided strong support for this model (Bateup et al., 2010; Durieux et al., 2009; Kravitz et al., 2010).”
Self-citationDay, M., Wang, Z., Ding, J., An, X., Ingham, C. A., Shering, A. F., Wokosin, D., Ilijic, E., Sun, Z., Sampson, A. R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1632 · Cited by 745 · cited 1×
“In general terms, these results are in agreement with results reported following DA depletion models, but in those models the change was preferentially observed in iMSNs (Day et al., 2006; Kita and Kita, 2011).”
Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models
Kreitzer, A. C., & Malenka, R. C. (2007) · Nature · doi:10.1038/nature05506 · Cited by 735 · cited 2×
“Consistent with previous studies (Chan et al., 2012; Kreitzer and Malenka, 2007), iMSNs showed higher intrinsic excitability than dMSNs in control Drd1-tdTomato;Drd2loxP/loxP mice (two-way repeated measures ANOVA; current 3 cell type interaction, F12, 444 = 3.149, p = 0.0003, n = 16–23).”
InfluentialNeurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum
Lovinger, D. M. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.01.008 · Cited by 488 · cited 1×
“…agents or genetic models of DA neuron degeneration, produces a pronounced motor deficit that closely resembles the motor symptoms characteristic of Parkinson’s disease (Bergman and Deuschl, 2002; Deumens et al., 2002; Lovinger, 2010; Palmiter, 2008; Schultz, 1982; Surmeier et al., 2014).”
Hernández-López, S., Tkatch, T., Perez-Garci, E., Galarraga, E., Bargas, J., Hamm, H., & Surmeier, D. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-08987.2000 · Cited by 443 · cited 1×
“Based on previous studies, we hypothesized that increased firing rate of iMSNs may account for the motor deficits of iMSN-Drd2KO mice (Hernandez-Lopez et al., 2000; Kravitz et al., 2010; Surmeier and Kitai, 1993).”
Palmiter, R. D. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1417.003 · Cited by 375 · cited 2×
“…agents or genetic models of DA neuron degeneration, produces a pronounced motor deficit that closely resembles the motor symptoms characteristic of Parkinson’s disease (Bergman and Deuschl, 2002; Deumens et al., 2002; Lovinger, 2010; Palmiter, 2008; Schultz, 1982; Surmeier et al., 2014).”
Bello, E. P., Mateo, Y., Gelman, D. M., Noaín, D., Shin, J. H., Low, M. J., Alvarez, V. A., Lovinger, D. M., & Rubinstein, M. (2011) · Nature Neuroscience · doi:10.1038/nn.2862 · Cited by 364 · cited 4×
“, 1990) and is opposite to the phenotype following targeted deletion of D2 autoreceptors (Anzalone et al., 2012; Bello et al., 2011).”
InfluentialSelf-citationSmith, R. J., Lobo, M. K., Spencer, S., & Kalivas, P. W. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.01.026 · Cited by 272
Activity of basal ganglia neurons during movement
DeLong, M. R. (1972) · Brain Research · doi:10.1016/0006-8993(72)90118-7 · Cited by 189
Cited by
Silencing Neurons: Tools, Applications, and Experimental Constraints
Wiegert, J. S., Mahn, M., Prigge, M., Printz, Y., & Yizhar, O. (2017) · Neuron · doi:10.1016/j.neuron.2017.06.050 · Cited by 312
Striatal Local Circuitry: A New Framework for Lateral Inhibition
Burke, D. A., Rotstein, H. G., & Alvarez, V. A. (2017) · Neuron · doi:10.1016/j.neuron.2017.09.019 · Cited by 268
Self-citationThe brain’s reward system in health and disease
Lewis, R. G., Florio, E., Punzo, D., & Borrelli, E. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-81147-1_4 · Cited by 170
“The effect of D2R on Per2 expression might not be direct, but mediated by the inhibitory regulation of iMSNs on dMSNs through collaterals (Lemos et al. 2016; Kharkwal et al. 2016b).”
BackgroundLahiri, A. K., & Bevan, M. D. (2020) · Neuron · doi:10.1016/j.neuron.2020.01.028 · Cited by 133
Xenias, H. S., Chen, C., Kang, S., Cherian, S., Situ, X., Shanmugasundaram, B., Liu, G., Scesa, G., Chan, C. S., & Parisiadou, L. (2022) · Communications Biology · doi:10.1038/s42003-022-04136-8 · Cited by 32
Metadata
- Authors
- Lemos, J. C., Friend, D. M., Kaplan, A. R., Shin, J. H., Rubinstein, M., Kravitz, A. V., & Alvarez, V. A.
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 90
- Issue
- 4
- Pages
- 824-838
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W2397032853
- Cited by
- 136
- References
- 10
- FWCI
- 10.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.